JULIE MEINE: Open Payments
NPI 1518089978 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 52 payments from 16 companies in 2025. Trend: 2023 $947 · 2024 $1,313 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $272 |
| Amgen Inc. | 11 | $194 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| ABIOMED | 3 | $98 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| Boston Scientific Corporation | 3 | $69 |
| Esperion Therapeutics, Inc. | 4 | $66 |
| PFIZER INC. | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
Products named: REPATHA, Wegovy, Ozempic, LEQVIO, ELIQUIS, General - Therapies, NEXLETOL, VYNDAQEL.
Industry payments across OH — which companies pay providers there.
